BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33074426)

  • 1. Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation.
    Mastrocostas K; Fischer S; Munoz-Schuffenegger P; Jang HJ; Dawson LA; Liu ZA; Sapisochin G; Kim TK
    Abdom Radiol (NY); 2021 Apr; 46(4):1572-1585. PubMed ID: 33074426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of hepatocellular carcinoma response to stereotactic body radiation using gadoxetate-enhanced MRI: A case series.
    Sharma HK; Kyriakakos C; Jabbour TE; Ward S; Buckstein M; Taouli B; Lewis S
    Eur J Radiol; 2023 Oct; 167():111077. PubMed ID: 37688918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series.
    Wang YF; Dai YH; Lin CS; Chang HC; Shen PC; Yang JF; Hsiang CW; Lo CH; Huang WY
    Radiat Oncol; 2021 Jan; 16(1):15. PubMed ID: 33446231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
    El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
    Mendiratta-Lala M; Gu E; Owen D; Cuneo KC; Bazzi L; Lawrence TS; Hussain HK; Davenport MS
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1063-1069. PubMed ID: 29029891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: An institutional experience.
    Chen B; Butler N; O'Rourke T; Hodgkinson P; Stuart K; Shih E; Leggett D; Pryor D; Liu H; Lee D
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):299-307. PubMed ID: 36825762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.
    Mendiratta-Lala M; Aslam A; Maturen KE; Westerhoff M; Maurino C; Parikh ND; Sun Y; Sonnenday CJ; Stein EB; Shampain KL; Kaza RK; Cuneo K; Masch W; Do RKG; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):704-714. PubMed ID: 34644607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.
    Vernuccio F; Godfrey D; Meyer M; Williamson HV; Salama JK; Niedzwiecki D; Stephens SJ; Ronald J; Palta M; Marin D
    AJR Am J Roentgenol; 2019 Dec; 213(6):1232-1239. PubMed ID: 31613663
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
    Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.
    Katz AW; Chawla S; Qu Z; Kashyap R; Milano MT; Hezel AF
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):895-900. PubMed ID: 22172906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
    Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
    Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.
    Zhang W; Xu AH; Wang W; Wu YH; Sun QL; Shu C
    BMC Cancer; 2019 Nov; 19(1):1041. PubMed ID: 31690274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
    Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
    Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
    Kelsey CR; Schefter T; Nash SR; Russ P; Barón AE; Zeng C; Gaspar LE
    Am J Clin Oncol; 2005 Dec; 28(6):576-80. PubMed ID: 16317267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    Oldrini G; Huertas A; Renard-Oldrini S; Taste-George H; Vogin G; Laurent V; Salleron J; Henrot P
    PLoS One; 2017; 12(4):e0176118. PubMed ID: 28441447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: evaluation of radiological and pathological response.
    Facciuto ME; Singh MK; Rochon C; Sharma J; Gimenez C; Katta U; Moorthy CR; Bentley-Hibbert S; Rodriguez-Davalos M; Wolf DC
    J Surg Oncol; 2012 Jun; 105(7):692-8. PubMed ID: 21960321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.